Financials EHR RESO Australian S.E.

Equities

EHX

Non-Gold Precious Metals & Minerals

End-of-day quote Australian S.E. 5-day change 1st Jan Change
- AUD -.--% Intraday chart for EHR RESO -.--% -.--%

Valuation

Fiscal Period: December 2023 2024 2025 2026
Capitalization 1 277.1 248.7 - -
Enterprise Value (EV) 1 277.1 218.7 133.9 85.71
P/E ratio -2.44 x 1.29 x 1.34 x 2.81 x
Yield - - - -
Capitalization / Revenue - 0.43 x 0.47 x 0.69 x
EV / Revenue - 0.38 x 0.26 x 0.24 x
EV / EBITDA - 0.83 x 0.54 x 0.69 x
EV / FCF - 8.41 x 1.58 x 1.79 x
FCF Yield - 11.9% 63.5% 56%
Price to Book - - - -
Nbr of stocks (in thousands) 1,421,205 1,421,205 - -
Reference price 2 0.1950 0.1800 0.1800 0.1800
Announcement Date 8/31/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2023 2024 2025 2026
Net sales 1 - 576 524 358
EBITDA 1 - 262 248 124
EBIT 1 - 176 177 77
Operating Margin - 30.56% 33.78% 21.51%
Earnings before Tax (EBT) 1 - 175 178 80
Net income 1 -27.99 145 146 69
Net margin - 25.17% 27.86% 19.27%
EPS 2 -0.0800 0.1390 0.1340 0.0640
Free Cash Flow 1 - 26 85 48
FCF margin - 4.51% 16.22% 13.41%
FCF Conversion (EBITDA) - 9.92% 34.27% 38.71%
FCF Conversion (Net income) - 17.93% 58.22% 69.57%
Dividend per Share - - - -
Announcement Date 8/31/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 S2
Net sales 1 257
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income -
Net margin -
EPS -
Dividend per Share -
Announcement Date -
1AUD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2023 2024 2025 2026
Net Debt 1 - - - -
Net Cash position 1 - 30 115 163
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 - 26 85 48
ROE (net income / shareholders' equity) - 60% 37% 14%
ROA (Net income/ Total Assets) - 20% 18% 8%
Assets 1 - 725 811.1 862.5
Book Value Per Share - - - -
Cash Flow per Share - - - -
Capex 1 - 145 61 26
Capex / Sales - 25.17% 11.64% 7.26%
Announcement Date 8/31/23 - - -
1AUD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.18 AUD
Average target price
0.4 AUD
Spread / Average Target
+122.22%
Consensus

Annual profits - Rate of surprise